Our company is owned and controlled by cancer patients, including our late founder Stephen Aldrich. Stephen was a Stage 4 adenocarcinoma of the esophagus patient who was able to use his full genome sequence data to make optimal treatment decisions regarding his cancer.

He obtained access to personalized immunotherapy options – including a personalized neoantigen vaccine, which led to his surviving and thriving for three full years beyond expectations. Our job is to enable patients to use their data as Stephen used his — to make optimal treatment decisions and directly access advanced therapy options.

MyCancerDB’s founding members are also its first customers. We are late-stage cancer patients with the goal of using our fundamental health data to eliminate our cancers and to achieve optimum health and wellness. We envision a world where all people dealing with incurable cancers are able to leverage their health data to quickly identify the best available, personalized treatment options.